The Oncologist

COVER STORIES

Current Issue

• Communicating About Phase I Trials: Objective Disclosures Are Only A First Step
• Phase II Study of Bevacizumab in Combination with Trastuzumab and Capecitabine as First-Line Treatment for HER-2-positive Locally Recurrent or Metastatic Breast Cancer
• Capecitabine Monotherapy: Review of Studies in First-Line HER-2-Negative Metastatic Breast Cancer
• The Impact of Diabetes Mellitus on Prognosis of Early Breast Cancer in Asia
• Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Oncotype DX®) and the PAM50 Breast Cancer Intrinsic Classifier™ in Early-Stage Estrogen Receptor–Positive Breast Cancer
• Tamoxifen Alters the Plasma Concentration of Molecules Associated with Cardiovascular Risk in Women with Breast Cancer Undergoing Chemotherapy
• Trastuzumab for Small HER-2+ Breast Cancer: Small Tumor, Big Decision
• A Pharmacodynamic Study of the P-glycoprotein Antagonist CBT-1® in Combination With Paclitaxel in Solid Tumors
• Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer
• Hypophysitis Induced by Monoclonal Antibodies to Cytotoxic T Lymphocyte Antigen 4: Challenges from a New Cause of a Rare Disease
• Lapatinib for Advanced or Metastatic Breast Cancer
• The European Medicines Agency Review of Cabazitaxel (Jevtana®) for the Treatment of Hormone-Refractory Metastatic Prostate Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
• Accumulating Evidence for a Drug–Drug Interaction Between Methotrexate and Proton Pump Inhibitors
• Folliculitis Induced by EGFR Inhibitors, Preventive and Curative Efficacy of Tetracyclines in the Management and Incidence Rates According to the Type of EGFR Inhibitor Administered: A Systematic Literature Review
• Time Course and Predictors for Cancer-Related Fatigue in a Series of Oropharyngeal Cancer Patients Treated with Chemoradiation Therapy
• Toward Individualized Breast Cancer Therapy: Translating Biological Concepts to the Bedside
• The Cardinal's Flight

HIGHLIGHTS

• Slow growing prostate cancer is still cancer
• Is lack of VTE protocol adherence putting cancer patients at risk? New study looks at the problem
   

ONLINE-ONLY NEWS

• Dramatic Response to Panitumumab and Bevacizumab in Metastatic Gallbladder Carcinoma
  This letter reports on a dramatic response to panitumumab and bevacizumab in a patient with widespread metastatic gall bladder carcinoma.